GlaxoSmithKline PLC (NYSE:GSK)

37.72
Delayed Data
As of Apr 02
 +0.02 / +0.05%
Today’s Change
31.43
Today|||52-Week Range
48.25
-19.73%
Year-to-Date
Is GlaxoSmithKline Stock a Buy?
Apr 01 / MotleyFool.com - Paid Partner Content
3 Stocks to Buy Ahead of the Next Market Crash
Mar 28 / MotleyFool.com - Paid Partner Content
Eli Lilly Licenses Immunology Drugs for Up to $880 Million
Mar 31 / MotleyFool.com - Paid Partner Content
2 Dividend Stocks Trading at Dirt-Cheap Prices
Mar 27 / MotleyFool.com - Paid Partner Content
Shares of Amarin Down 68% After Losing a Patent Lawsuit for Vascepa
Mar 30 / MotleyFool.com - Paid Partner Content
Why Sanofi's Coronavirus Vaccine Work Hasn't Helped Its Stock
Mar 21 / MotleyFool.com - Paid Partner Content
3 Top Stocks to Buy With Your $1,200 Stimulus Check
Mar 28 / MotleyFool.com - Paid Partner Content
 

Today’s Trading

Previous close37.70
Today’s open37.00
Day’s range36.68 - 37.80
Volume4,839
Average volume (3 months)4,263,205
Market cap$91.5B
Data as of 3:59pm ET, 04/02/2020

Growth & Valuation

Earnings growth (last year)+21.84%
Earnings growth (this year)-9.08%
Earnings growth (next 5 years)+2.81%
Revenue growth (last year)+4.78%
P/E ratio16.4
Price/Sales2.74
Price/Book5.69

Competitors

 Today’s
change
Today’s
% change
SNYSanofi+0.60+1.40%
ABBVAbbVie-0.09-0.12%
NVONovo Nordisk-0.44-0.74%
----
Data as of 4:00pm ET, 04/02/2020

Financials

Next reporting dateApril 29, 2020
EPS forecast (this quarter)$0.74
Annual revenue (last year)$43.1B
Annual profit (last year)$5.9B
Net profit margin13.76%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Major
No executives to display
Corporate headquarters
Middlesex, Greater London

Forecasts